Literature DB >> 17065259

Use of internally controlled real-time genome amplification for detection of variola virus and other orthopoxviruses infecting humans.

C G Fedele1, A Negredo, F Molero, M P Sánchez-Seco, A Tenorio.   

Abstract

Smallpox, once a devastating disease caused by Variola virus, a member of the Orthopoxvirus genus, was eradicated in 1980. However, the importance of variola virus infections has been stressed widely in the last few years, particularly following recent social events in the world. Today, variola virus is considered to be one of the most significant agents with potential use as a biological weapon. In this study we developed an internally controlled real-time PCR assay for rapid detection and simultaneous differentiation of variola virus from other orthopoxviruses. The assay is based on TaqMan 3'-minor groove binder (MGB) chemistry and uses generic primers, designed in highly conserved genomic regions of the crmB gene, and three TaqMan MGB probes designed to identify orthopoxviruses, variola virus, and an internal control. The results obtained suggest that the assay is rapid, sensitive, specific, and suitable for the generic detection of orthopoxviruses and the identification of variola virus and avoids false-negative results in a single reaction tube.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065259      PMCID: PMC1698395          DOI: 10.1128/JCM.00276-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

Review 1.  The threat of bioterrorism returns the fear of smallpox.

Authors:  R M Atlas
Journal:  Curr Opin Microbiol       Date:  1998-12       Impact factor: 7.934

Review 2.  Agents of bioterrorism. Preparing for bioterrorism at the community health care level.

Authors:  J M Miller
Journal:  Infect Dis Clin North Am       Date:  2001-12       Impact factor: 5.982

3.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

4.  Species-level identification of orthopoxviruses with an oligonucleotide microchip.

Authors:  Sergey Lapa; Maxim Mikheev; Sergei Shchelkunov; Vladimir Mikhailovich; Alexander Sobolev; Vladimir Blinov; Igor Babkin; Alexander Guskov; Elena Sokunova; Alexander Zasedatelev; Lev Sandakhchiev; Andrei Mirzabekov
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Detection of smallpox virus DNA by LightCycler PCR.

Authors:  Mark J Espy; Franklin R Cockerill III; Richard F Meyer; Michael D Bowen; Gregory A Poland; Ted L Hadfield; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Detection and identification of orthopoxviruses using a generic nested PCR followed by sequencing.

Authors:  M P Sánchez-Seco; L Hernández; J M Eiros; A Negredo; G Fedele; A Tenorio
Journal:  Br J Biomed Sci       Date:  2006       Impact factor: 3.829

Review 7.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  D A Henderson; T V Inglesby; J G Bartlett; M S Ascher; E Eitzen; P B Jahrling; J Hauer; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  1999-06-09       Impact factor: 56.272

8.  Detection and differentiation of old world orthopoxviruses: restriction fragment length polymorphism of the crmB gene region.

Authors:  V N Loparev; R F Massung; J J Esposito; H Meyer
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 9.  Smallpox: a potential agent of bioterrorism.

Authors:  Richard J Whitley
Journal:  Antiviral Res       Date:  2003-01       Impact factor: 5.970

10.  Real-time PCR assay to detect smallpox virus.

Authors:  M Sofi Ibrahim; David A Kulesh; Sharron S Saleh; Inger K Damon; Joseph J Esposito; Alan L Schmaljohn; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  5 in total

1.  Orthopoxvirus detection in environmental specimens during suspected bioterror attacks: inhibitory influences of common household products.

Authors:  Andreas Kurth; John Achenbach; Liljia Miller; Ian M Mackay; Georg Pauli; Andreas Nitsche
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

2.  A Model to Detect Autochthonous Group 1 and 2 Brazilian Vaccinia virus Coinfections: Development of a qPCR Tool for Diagnosis and Pathogenesis Studies.

Authors:  Rafael Calixto; Graziele Oliveira; Maurício Lima; Ana Cláudia Andrade; Giliane de Souza Trindade; Danilo Bretas de Oliveira; Erna Geessien Kroon
Journal:  Viruses       Date:  2017-12-30       Impact factor: 5.048

3.  Characterization of Two Historic Smallpox Specimens from a Czech Museum.

Authors:  Petr Pajer; Jiri Dresler; Hana Kabíckova; Libor Písa; Pavel Aganov; Karel Fucik; Daniel Elleder; Tomas Hron; Vitezslav Kuzelka; Petr Velemínsky; Jana Klimentova; Alena Fucikova; Jaroslav Pejchal; Rita Hrabakova; Vladimir Benes; Tobias Rausch; Pavel Dundr; Alexander Pilin; Radomir Cabala; Martin Hubalek; Jan Stríbrny; Markus H Antwerpen; Hermann Meyer
Journal:  Viruses       Date:  2017-07-27       Impact factor: 5.048

4.  Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects.

Authors:  Eva Orviz; Anabel Negredo; Oskar Ayerdi; Ana Vázquez; Ana Muñoz-Gomez; Sara Monzón; Petunia Clavo; Angel Zaballos; Mar Vera; Patricia Sánchez; Noemi Cabello; Pilar Jiménez; Jorge A Pérez-García; Sarai Varona; Jorge Del Romero; Isabel Cuesta; Alberto Delgado-Iribarren; Montse Torres; Iñigo Sagastagoitia; Gustavo Palacios; Vicente Estrada; Maria Paz Sánchez-Seco
Journal:  J Infect       Date:  2022-07-10       Impact factor: 38.637

5.  Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.

Authors:  Debra C Quenelle; Mark N Prichard; Kathy A Keith; Dennis E Hruby; Robert Jordan; George R Painter; Alice Robertson; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.938

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.